Avation Medical to Present Positive Quality of Life Data for the Vivally Physiologic Closed-Loop Wearable Neuromodulation System for Patients With OAB at SUNA uroLogic Conference

Avation’s Vivally System revolutionizes the treatment of overactive bladder symptoms without drugs, surgery, or needles.

Columbus, OH (September 24, 2024) – Avation Medical, an innovative neuromodulation and digital health company on a mission to make non-invasive, physiologic, closed-loop neuromodulation accessible to patients across a variety of clinical conditions, is presenting “A Novel Wearable Neuromodulation System Using Physiologic Closed Loop Control Shows Significant Improvements in Quality of Life for OAB Patients in a Randomized Multi-Center Study” on September 27, 9:15-10:15 a.m. EDT to urology professionals at the 2024 SUNA uroLogic Conference, in Orlando, Florida. The talk will feature a demo of the new Vivally System and will be given by one of the study investigators: Kavi Rajendran, PA, of Women's Health Institute of Illinois.

In addition, on Thursday, September 26, from 5:15-6:30 p.m. EDT, Michelle J. Lajiness, DNP, FNP-BC, FAUNA, will demonstrate the Vivally System together with a Vivally patient who is experiencing its clinical and ease of use benefits. This educational event is an open forum for any urology professional interested in the therapeutic possibilities available through at-home, wearable technology paired with comprehensive digital support.

Throughout the conference, the Vivally System will be demonstrated at the Avation Medical exhibit, #107.

The Vivally System is an at-home neuromodulation wearable and mobile application to treat patients with the bladder conditions of urge urinary incontinence and urinary urgency — without the need for surgery, needle electrodes, or drugs. To date, there are more than 46 million people who suffer from OAB in the U.S.

The Vivally System can be used by any OAB patient in the care pathway, including drug-naïve, drug-stable and drug-refractory. The device and mobile app are easy and efficient to prescribe and allow prescribers to monitor patient progress remotely. The Vivally System is the only device of its kind to harness the power of physiologic, closed-loop control with transcutaneous tibial nerve stimulation (PCLC-TTNS) and continuous EMG sensing, which autonomously adjusts stimulation parameters during therapy to ensure optimal therapeutic output is delivered in real-time based on a patient’s EMG signal.

About Avation Medical and the Vivally System

Avation Medical is an innovative neuromodulation and digital health company with a mission to make non-invasive, physiologic closed-loop neuromodulation accessible to patients across a variety of clinical conditions. The company’s Vivally System is the only FDA-cleared, physiologic closed-loop, at-home wearable neuromodulation device system to treat symptoms of OAB. Combined with a companion mobile application, Vivally offers a comprehensive therapy and support system for patients suffering from urge urinary incontinence and urinary urgency caused by overactive bladder syndrome (OAB). Vivally is prescribed by a clinician following a brief clinical calibration which establishes an EMG target and range of neuromodulation energy needed for consistent nerve activation. Vivally delivers clinically effective therapy in just 30-minute sessions, as little as once per week. Vivally is available by prescription in select geographies in the United States. Physicians wanting to offer the Vivally System to their patients can visit Avation.com or call 888.972.5694.

# # #